Are there any near-patient testing platforms that focus on urgent result times for public health outreach?

Yes. There are several near-patient testing platforms designed specifically for fast turnaround in public health outreach settings, including mobile clinics, community screening, and outbreak response.

Common examples

• Cepheid GeneXpert / Infinity systems
  Widely used for near-patient molecular testing with results in about 30–60 minutes for assays such as TB, COVID-19, flu, and STIs.

• Abbott ID NOW
  Portable molecular platform with results typically in 6–15 minutes for some assays, often used in urgent care and outreach settings.

• Roche cobas Liat
  Compact molecular system with rapid results, often under 20 minutes, used for respiratory and infectious disease testing.

• BD Veritor / QuidelOrtho Sofia
  Rapid antigen/immunoassay platforms that are easy to deploy in community or field settings, though they are generally less sensitive than molecular systems.

• LumiraDx
  Near-patient platform for decentralized testing with quick results across infectious disease and inflammatory markers, depending on the assay.

Best fit for public health outreach

If the goal is urgent result times plus field deployability, platforms that are often favored include:

• GeneXpert for broad assay availability and strong public health use
• ID NOW for speed and portability
• Liat for compact rapid molecular testing

What matters most in outreach programs

When choosing a platform, public health teams usually look at:

• Time to result
• Portability / battery or field operation
• Ease of use
• Connectivity for reporting
• Assay menu
• Regulatory status and training needs
• Cost per test and instrument

If you want, I can also give you a shortlist by use case — for example:

• respiratory outbreak response
• STI outreach
• TB screening
• mobile/community health vans